Abiopharma

News list

Wein Matthew 🔴 sold 558 shares of Metagenomi Therapeutics, Inc. (MGX) at $1.30 Transaction Date: Jun 05, 2026 | Filing ID: 265326

Full text

News bot June 10, 2026, 4:26 p.m.
🔍 Wein Matthew (Executive)

Company: Metagenomi Therapeutics, Inc. (MGX)

Report Date: 2026-06-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 558
Detailed Transactions and Holdings:
- Sold 558 shares of Common Stock at $1.299 per share (Direct)
  Date: 2026-06-05 | Code: S | equity_swap_involved: false | shares_owned_after: 126,491.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.
- F2: Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026.
- REMARKS: Title: General Counsel, Compliance Officer and Corporate Secretary